Abeona Therapeutics Inc vs Clorox Co — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Clorox Co trades at $107 (market cap $13.09B). The key difference: Clorox Co is far larger — about 31.1× Abeona Therapeutics Inc's market cap, and Clorox Co pays a 4.62% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | CLX | |
|---|---|---|
Market Cap | $421.19M | $13.09B |
Sector | Health | Consumer Staples |
52-Week High | $7.45 | $127.16 |
52-Week Low | $4.17 | $86.12 |
Enterprise Value | $276.10M | $18.47B |
Dividend Yield | — | 4.62% |
Trailing returns across standard periods
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →With a history dating back more than 100 years, Clorox now plays in a variety of categories across the consumer products space, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water-filtration products, and natural personal-care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. Just shy of 85% of Clorox's sales stem from its home turf.
Read more on CLX →